| Unique ID issued by UMIN | UMIN000054614 |
|---|---|
| Receipt number | R000062401 |
| Scientific Title | A comparative study of the discontinuation rate of Intravenous patient-controlled analgesia used after posterior spinal fusion surgery with intraoperative ondansetron administration. A |
| Date of disclosure of the study information | 2024/06/10 |
| Last modified on | 2024/06/09 17:07:39 |
A comparative study of the discontinuation rate of Intravenous patient-controlled analgesia used after posterior spinal fusion surgery with intraoperative ondansetron administration. 1
A comparative study of the discontinuation rate of Intravenous patient-controlled analgesia used after posterior spinal fusion surgery with intraoperative ondansetron administration.
A comparative study of the discontinuation rate of Intravenous patient-controlled analgesia used after posterior spinal fusion surgery with intraoperative ondansetron administration. A
A comparative study of the discontinuation rate of Intravenous patient-controlled analgesia used after posterior spinal fusion surgery with intraoperative ondansetron administration. B
| Japan |
posterior spinal fusion surgery
| Anesthesiology |
Others
NO
The purpose of this study is to compare whether intraoperative administration of ondansetron affects the discontinuation rate of transvenous patient-controlled analgesia after posterior spinal fusion surgery.
Efficacy
the discontinuation rate of transvenous patient-controlled analgesia
Interventional
Parallel
Randomized
Individual
Single blind -participants are blinded
Active
2
Treatment
| Medicine |
Anesthesia is administered by inhalation with sevoflurane and remifentanil. Fentanyl 9 mcg/kg and acetaminophen 15 mg/kg are administered as intraoperative analgesics. Transvenous patient-controlled analgesia is used for a total of 60 ml of fentanyl, saline, and 5 mg of droperidol to achieve 0.5 mcg/kg/h of fentanyl when used at 2 ml/h. During surgery, 4 mg of ondansetron and 1.25 mg of droperidol are administered.
Anesthesia is administered by inhalation with sevoflurane and remifentanil. Fentanyl 9 mcg/kg and acetaminophen 15 mg/kg are administered as intraoperative analgesics. Transvenous patient-controlled analgesia is used for a total of 60 ml of fentanyl, saline, and 5 mg of droperidol to achieve 0.5 mcg/kg/h of fentanyl when used at 2 ml/h. During surgery, 1.25 mg of droperidol are administered.
| 18 | years-old | <= |
| Not applicable |
Male and Female
ASA-1 or 2 phyisical status patients undergoing posterior spinal fusion between 1 or 2 vertebrae from the date of approval by the Ethics Review Committee in 2024 and the date of the Institutional Director's approval until March 31, 2025.
1. Asthma 2. Long QT syndrome 3. Patients who did not give consent
50
| 1st name | Soejima |
| Middle name | |
| Last name | Yuki |
Nagasaki rosai hospitsl
Anesthesiology
857-0134
2-12-5 Setogoe, Sasebo ciity, Nagasaki
0956-49-2191
shomu@nagasaki.johas.go.jp
| 1st name | Soejima |
| Middle name | |
| Last name | Yuki |
Nagasaki rosai hospital
Anesthesiology
8570134
2-12-5 Setogoe, Sasebo ciity, Nagasaki
09020869792
yukisoejima08@gmail.com
Nagasaki rosai hospital, Anesthesiology, Yuki Soejima
Yuki Soejima
Nagasaki rosai hospital
Other
Nagasaki rosai hospital
2-12-5 Setogoe, Sasebo ciity, Nagasaki
0956492191
shomu@nagasaki.johas.go.jp
YES
0513
Nagasaki rosai hospital
| 2024 | Year | 06 | Month | 10 | Day |
Unpublished
Enrolling by invitation
| 2024 | Year | 03 | Month | 18 | Day |
| 2024 | Year | 03 | Month | 18 | Day |
| 2024 | Year | 04 | Month | 01 | Day |
| 2025 | Year | 04 | Month | 01 | Day |
| 2024 | Year | 06 | Month | 09 | Day |
| 2024 | Year | 06 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062401